$CORZ

DUCHENE TODD M sold $293K of CORZ

DUCHENE TODD M (See remarks) sold 10,000 shares of Core Scientific, Inc./tx (CORZ) at an average of $29.29 ($29.11–$29.88, $0.29M total) across 2 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUCHENE TODD M
Published Jun 24, 2026, 8:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CORZ
Neutral
high confidence
Mentioned
$CORZ
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price range, and that it was executed under a 10b5-1 plan; it does not include any new company fundamentals.

02

Market read

This is a routine insider selling disclosure; it may slightly influence sentiment but provides no new catalyst for valuation.

03

What to watch

Traders may overreact to insider sales; the key missing context is whether there were concurrent buys, changes in other insiders’ activity, or any company event on/around the same dates.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-24 after sales executed 2026-06-22.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Core Scientific, Inc.

Company-level read

Ticker impact

$CORZNeutralHigh confidence
Context

Core Scientific insider DUCHENE TODD M sold $292,939 of CORZ shares via an open-market sale under a 10b5-1 plan on 2026-06-22.

Expected impact

Limited near-term impact; any effect is likely short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is a Form 4 showing a pre-arranged 10b5-1 sale with no accompanying company-specific news, guidance, or event.

Market effects

No direct sector read-through; this is a single-company insider transaction without new operational/regulatory information.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may not reflect bearish expectations; it can be consistent with neutral/ongoing compensation or diversification needs.

Key entities

  • Core Scientific, Inc.

    Subject of the Form 4 insider transaction disclosure (CORZ).

  • DUCHENE TODD M

    Officer who executed the open-market sale under a pre-arranged 10b5-1 plan.

Related articles

$CORZMedAI 8/10

Core Scientific lands USD$14B AMD AI infrastructure partnership

Core Scientific (CORZ) said it signed a 15-year AI infrastructure partnership with AMD (AMD) covering 529 MW of U.S. capacity, with potential contracted revenue above $14B. AMD can reserve an additional 1,925 MW through Dec. 28, 2028, deploying from 2027. Warrants allow AMD to buy up to 30M CORZ shares at $23.47.

$AMDMed

AMD's Core Scientific deal is bigger than the headline number

Nine months ago, Core Scientific shareholders turned down real money. They rejected a $9 billion buyout offer from CoreWeave, according to CNBC. Shareholders bet the company was worth more standing alone. On Tuesday, that bet started to look prescient. AMD agreed to lease more than 500 megawatts of Core Scientific's U.S. data center capacity, according to a press release from the companies. The stock market did not treat the news as a simple win for either side.